Global Rheumatic Heart Disease Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 106

Report ID: 3929

Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged.
Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expenditure by government to tackle rising prevalence of cardiovascular disease is another motivating factor for the market.
In 2018, the global Rheumatic Heart Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Rheumatic Heart Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rheumatic Heart Disease development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Bayer
BIOTRONIK
Boston Scientific
Bristol-Myers Squibb
C. R. Bard
Cardinal Health
Cook Medical
Roche
GE Healthcare
InterValve
Novartis
On-X Life Technologies
Osypka Medical
Otsuka
PerkinElmer
Pfizer
Reckitt Benckiser
Siemens Healthineers
Toray

Market segment by Type, the product can be split into
Valve
Myocarditis
Pericarditis

Market segment by Application, split into
Hospital
Diagnostic Centre
Research Centre

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rheumatic Heart Disease status, future forecast, growth opportunity, key market and key players.
To present the Rheumatic Heart Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rheumatic Heart Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rheumatic Heart Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Valve
1.4.3 Myocarditis
1.4.4 Pericarditis
1.5 Market by Application
1.5.1 Global Rheumatic Heart Disease Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Diagnostic Centre
1.5.4 Research Centre
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Rheumatic Heart Disease Market Size
2.2 Rheumatic Heart Disease Growth Trends by Regions
2.2.1 Rheumatic Heart Disease Market Size by Regions (2014-2025)
2.2.2 Rheumatic Heart Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Rheumatic Heart Disease Market Size by Manufacturers
3.1.1 Global Rheumatic Heart Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Rheumatic Heart Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rheumatic Heart Disease Market Concentration Ratio (CR5 and HHI)
3.2 Rheumatic Heart Disease Key Players Head office and Area Served
3.3 Key Players Rheumatic Heart Disease Product/Solution/Service
3.4 Date of Enter into Rheumatic Heart Disease Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Rheumatic Heart Disease Market Size by Type (2014-2019)
4.2 Global Rheumatic Heart Disease Market Size by Application (2014-2019)

5 United States
5.1 United States Rheumatic Heart Disease Market Size (2014-2019)
5.2 Rheumatic Heart Disease Key Players in United States
5.3 United States Rheumatic Heart Disease Market Size by Type
5.4 United States Rheumatic Heart Disease Market Size by Application

6 Europe
6.1 Europe Rheumatic Heart Disease Market Size (2014-2019)
6.2 Rheumatic Heart Disease Key Players in Europe
6.3 Europe Rheumatic Heart Disease Market Size by Type
6.4 Europe Rheumatic Heart Disease Market Size by Application

7 China
7.1 China Rheumatic Heart Disease Market Size (2014-2019)
7.2 Rheumatic Heart Disease Key Players in China
7.3 China Rheumatic Heart Disease Market Size by Type
7.4 China Rheumatic Heart Disease Market Size by Application

8 Japan
8.1 Japan Rheumatic Heart Disease Market Size (2014-2019)
8.2 Rheumatic Heart Disease Key Players in Japan
8.3 Japan Rheumatic Heart Disease Market Size by Type
8.4 Japan Rheumatic Heart Disease Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Rheumatic Heart Disease Market Size (2014-2019)
9.2 Rheumatic Heart Disease Key Players in Southeast Asia
9.3 Southeast Asia Rheumatic Heart Disease Market Size by Type
9.4 Southeast Asia Rheumatic Heart Disease Market Size by Application

10 India
10.1 India Rheumatic Heart Disease Market Size (2014-2019)
10.2 Rheumatic Heart Disease Key Players in India
10.3 India Rheumatic Heart Disease Market Size by Type
10.4 India Rheumatic Heart Disease Market Size by Application

11 Central & South America
11.1 Central & South America Rheumatic Heart Disease Market Size (2014-2019)
11.2 Rheumatic Heart Disease Key Players in Central & South America
11.3 Central & South America Rheumatic Heart Disease Market Size by Type
11.4 Central & South America Rheumatic Heart Disease Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rheumatic Heart Disease Introduction
12.1.4 Abbott Laboratories Revenue in Rheumatic Heart Disease Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Bayer
12.2.1 Bayer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rheumatic Heart Disease Introduction
12.2.4 Bayer Revenue in Rheumatic Heart Disease Business (2014-2019)
12.2.5 Bayer Recent Development
12.3 BIOTRONIK
12.3.1 BIOTRONIK Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rheumatic Heart Disease Introduction
12.3.4 BIOTRONIK Revenue in Rheumatic Heart Disease Business (2014-2019)
12.3.5 BIOTRONIK Recent Development
12.4 Boston Scientific
12.4.1 Boston Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rheumatic Heart Disease Introduction
12.4.4 Boston Scientific Revenue in Rheumatic Heart Disease Business (2014-2019)
12.4.5 Boston Scientific Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rheumatic Heart Disease Introduction
12.5.4 Bristol-Myers Squibb Revenue in Rheumatic Heart Disease Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 C. R. Bard
12.6.1 C. R. Bard Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rheumatic Heart Disease Introduction
12.6.4 C. R. Bard Revenue in Rheumatic Heart Disease Business (2014-2019)
12.6.5 C. R. Bard Recent Development
12.7 Cardinal Health
12.7.1 Cardinal Health Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rheumatic Heart Disease Introduction
12.7.4 Cardinal Health Revenue in Rheumatic Heart Disease Business (2014-2019)
12.7.5 Cardinal Health Recent Development
12.8 Cook Medical
12.8.1 Cook Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rheumatic Heart Disease Introduction
12.8.4 Cook Medical Revenue in Rheumatic Heart Disease Business (2014-2019)
12.8.5 Cook Medical Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rheumatic Heart Disease Introduction
12.9.4 Roche Revenue in Rheumatic Heart Disease Business (2014-2019)
12.9.5 Roche Recent Development
12.10 GE Healthcare
12.10.1 GE Healthcare Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rheumatic Heart Disease Introduction
12.10.4 GE Healthcare Revenue in Rheumatic Heart Disease Business (2014-2019)
12.10.5 GE Healthcare Recent Development
12.11 InterValve
12.12 Novartis
12.13 On-X Life Technologies
12.14 Osypka Medical
12.15 Otsuka
12.16 PerkinElmer
12.17 Pfizer
12.18 Reckitt Benckiser
12.19 Siemens Healthineers
12.20 Toray

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details